These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8447345)

  • 41. Controlling pharmacy costs in the NC Medicaid program.
    Dobson LA
    N C Med J; 2003; 64(6):280-2. PubMed ID: 14983617
    [No Abstract]   [Full Text] [Related]  

  • 42. Sword or shield? An overview and competitive analysis of the marketing of "authorized generics".
    Zain S
    Food Drug Law J; 2007; 62(4):739-77. PubMed ID: 18557229
    [No Abstract]   [Full Text] [Related]  

  • 43. Firms help companies carve savings from drug spending.
    Kenkel PJ
    Mod Healthc; 1992 May; 22(21):34. PubMed ID: 10118148
    [No Abstract]   [Full Text] [Related]  

  • 44. The association of insurance type with costs of dispensed drugs.
    Mott DA; Kreling DH
    Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The utility of an organized drug data base in determining contributions to the quality and efficiency of Medicaid programs.
    Roden DR; Kennard LH
    Drug Inf J; 1975; 9(2-3):131-7. PubMed ID: 10297122
    [No Abstract]   [Full Text] [Related]  

  • 46. Point/counterpoint. The HMO pharmacy benefit. In-house pharmacy administration: the benefits of integration.
    Penna P
    HMO; 1995; 36(4):56, 58-9. PubMed ID: 10166487
    [No Abstract]   [Full Text] [Related]  

  • 47. A national imperative.
    Augusti M
    Adm Radiol J; 1996 Jun; 15(6):37-8. PubMed ID: 10159372
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-26. PubMed ID: 19301435
    [No Abstract]   [Full Text] [Related]  

  • 49. Pharmaceuticals: pharmaceutical cost controls--2005. End of Year Issue Brief.
    Seay M; Varma P
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prescription drug prices in Canada.
    Gross D
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123
    [No Abstract]   [Full Text] [Related]  

  • 51. Coupon programs curb antihistamine utilization.
    Berberabe T
    Manag Care; 2003 Aug; 12(8):28-9. PubMed ID: 12966848
    [No Abstract]   [Full Text] [Related]  

  • 52. Economic consequences of the maximum allowable cost program to the entire profession of pharmacy.
    Paul SH
    Med Mark Media; 1979 Aug; 14(8):19-26. PubMed ID: 10243270
    [No Abstract]   [Full Text] [Related]  

  • 53. Standing on your own feet.
    Apple WS
    J Am Pharm Assoc; 1974 Jun; 14(6):278-80. PubMed ID: 4840422
    [No Abstract]   [Full Text] [Related]  

  • 54. Ethics, profit and patients: when pharmaceutical companies sponsor medical meetings.
    Barton L
    J Hosp Mark; 1993; 8(1):71-82. PubMed ID: 10135504
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Food and Drug Administration drug registration and listing system.
    Slavin M
    Drug Inf J; 1975; 9(2-3):239-40. PubMed ID: 10236978
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-27. PubMed ID: 18345555
    [No Abstract]   [Full Text] [Related]  

  • 57. A discussion of pharmaceutical industry practices viewed as illegal by the federal government.
    Nino K
    Health Care Law Mon; 1999 Nov; ():8-16. PubMed ID: 11067433
    [No Abstract]   [Full Text] [Related]  

  • 58. Strategies for acquiring affordable medications for seniors.
    Morris KJ
    Nurs Clin North Am; 2005 Mar; 40(1):51-62, vi. PubMed ID: 15733946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A critical analysis of studies of state drug reimbursement policies: research in need of discipline.
    Soumerai SB; Ross-Degnan D; Fortess EE; Abelson J
    Milbank Q; 1993; 71(2):217-52. PubMed ID: 8510601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medicaid and indigent care issue brief: Medicaid: provider reimbursement: year end report-2003.
    Johnson P
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-25. PubMed ID: 14969256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.